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Use of the rSpaA415 antigen indicates low
rates of Erysipelothrix rhusiopathiae
infection in farmed cattle from the United
States of America and Great Britain
Ana I. Cubas Atienzar1* , Priscilla F. Gerber2 and Tanja Opriessnig1,3
Abstract
Background: Clinical cases of Erysipelothrix rhusiopathiae, a zoonotic gram-positive bacterium, have been reported
in many ruminant species, including in cattle, deer, moose and muskoxen. Fatal cases have been repeatedly
reported in cattle over the years but to date there is only one Japanese study investigating the seroprevalence of
this bacterium in cattle using the growth agglutination test (GAT). This technique is subjective, time-consuming,
expensive and hazardous compared to modern serological tests such as enzyme-linked immunosorbent assays
(ELISA) or the newly developed fluorescent microbead-based immunoassays (FMIA).
Results: The FMIA based on the surface protein SpaA (rSpaA415) antigen of E. rhusiopathiae developed in this
study had an almost perfect agreement with the GAT (k = 0.83) and showed a sensitivity of 89.7% and a specificity
of 92.9% when compared to the GAT. Overall, detection rates of E. rhusiopathiae antibody positive samples were
13.8% (51/370) in British herds and 6% (12/200) in US herds. Positive cattle were present in 34.3% (24/70) of the
investigated British farms and in 34.7% (8/23) of the US farms with an on-farm prevalence of 7.1 to 100% for the
British farms and 8.3–30% for the US farms.
Conclusions: FMIA is a fast, safe and economic alternative to the GAT for the diagnosis of E. rhusiopathiae in cattle.
This work is the first seroprevalence study of E. rhusiopathiae in healthy farmed cattle in Great Britain and the US
and revealed that infection occurs at a low level. Further investigations to evaluate risks of zoonotic transmission
when handling cattle are needed.
Keywords: Erysipelothrix rhusiopathiae, Cattle, Prevalence, US, Great Britain, Growth agglutination test, Fluorescent
microbead-based immunoassay, Enzyme-linked immunosorbent assay
Background
Erysipelothrix is a gram-positive bacterium. The genus
Erysipelothrix contains four relevant species associated
with 28 different serotypes; Erysipelothrix rhusiopathiae
(serotypes 1a, 1b, 2, 4, 5, 6, 8, 9, 11, 12, 15, 16, 17, 19,
21, 23 and N), Erysipelothrix tonsillarum (serotypes 3, 7,
10, 14, 20, 22, 24, 25 and 26), Erysipelothrix sp. strain 1
(serotype 13) and Erysipelothrix sp. strain 2 (serotype 18)
[1]. Erysipelothrix rhusiopathiae is considered to contain
pathogenic isolates known as the etiologic agent of swine
erysipelas associated with sporadic cases or larger out-
breaks of major economic importance [2]. Besides pigs,
E. rhusiopathiae can cause a wide range of diseases in
other species such as sheep, fish, poultry, cattle and
humans [3–6]. Infections in humans are primarily a re-
sult of contact with infected animals and are presented
either as a localized cutaneous lesion called erysipeloid,
as a generalised cutaneous lesion, or as a septicaemic
form which is often associated with endocarditis [7].
Recently, E. rhusiopathiae has been isolated in increas-
ing frequency from ruminants, especially from farmed
cattle (Bos taurus) [4, 5]. Most of the clinical cases in
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cattle are observed in young calves presenting septicae-
mia [8], with abscesses in the liver and lungs [9], ence-
phalomeningitis [10], or polyserositis and arthritis [11].
Erysipelothrix rhusiopathiae has been associated with
unusual mortality events in muskoxen (Ovibos moscha-
tus wardi) in the Canadian Arctic Archipelago [12]. Dur-
ing the years 2009–2011, a total of 22 muskoxen were
found dead during expeditions in the Canadian Arctic
Archipelago and in 2012 approximately 150 muskoxen
were found dead; E. rhusiopathiae serotype 5 was con-
firmed by serotyping isolates from tissues of these ani-
mals [12]. Interestingly, E. rhusiopathiae serotype 5 was
also isolated from a fatal case of metritis in a Norwegian
heifer [13] and from a fatal case of acute multifocal nec-
rotic hepatitis in a white tailored reindeer in Iowa, USA
[14]. In Canada, the death of three elks (Alces alces) was
linked to a septicaemia caused by Erysipelothrix of sero-
type 17 [15].
During studies in Japanese abattoirs, Erysipelothrix was
isolated from 6.4% of 1236 healthy, slaughtered cattle [16]
which demonstrates that cattle may be subclinically in-
fected with the bacterium. A follow-up epidemiological
study using the growth agglutination test (GAT) to detect
anti-Erysipelothrix antibodies in Japanese cattle found that
76% of 854 healthy cattle had detectable antibodies [3].
The same study also found a higher rate of seropositive
cattle in areas also having swine industry [3]. This data
could indicate that Erysipelothrix is mainly transmitted by
pigs although cattle may also act as a vehicle for its distri-
bution [5, 16]. In support of this, Erysipelothrix was iso-
lated from cattle slurry [3] which could enhance the
bacterium’s ability to spread as Erysipelothrix can survive
in soil contaminated with faecal material [4].
Previously studies investigating antibodies in cattle
have been carried out using solely GAT. GAT has been
extensively used in pigs and chickens and it has shown a
good correlation between the antibody titres and im-
mune status in vaccinated pigs [17] and challenged
chickens [18] but this correlation has not yet been inves-
tigated in cattle. The use of GAT in pigs and chickens
was replaced by developed enzyme-linked immunosorb-
ent assays (ELISAs) and fluorescent microbead-based
immunoassays (FMIAs) [6, 19–22] due to their ability to
permit the testing of large numbers of samples in a short
time, while giving objective results. FMIAs are based on
a liquid suspension array designed for multiplex testing.
This technology utilizes magnetic microspheres filled
with a distinct red and infrared fluorescent dyes, result-
ing in up to 100 sets of different microspheres each of
which with its own unique spectral address allowing
heavy multiplexing in one reaction well.
Although Erysipelothrix and antibodies against it
have been detected in healthy cattle in Japan [3–5],
data is lacking for the distribution of Erysipelothrix in
cattle across Europe and North America where its
epidemiological importance is not known.
A highly sensitive (96.5%) and specific (100%) ELISA
was recently developed for the detection of Erysipelo-
thrix in swine using a recombinant SpaA (rSpaA415) [6].
This assay was then further improved by adapting it into
an FMIA [21]. Compared to the ELISA, the FMIA is
more sensitive and its format requires less serum, less
antigen and allows multiplexing thereby further reducing
cost.
This study aimed to investigate the antibody distribu-
tion against Erysipelothrix in cattle in Great Britain and
the US to increase the knowledge of its epidemiological
significance and to develop an ELISA and FMIA test
using rSpaA415 antigen for the detection of antibodies
against Erysipelothrix in cattle to overcome the disad-
vantages of GAT.
Results
Development and optimisation of rSpaA415 FMIA and
ELISA and cut-off evaluation using the GAT as the
reference assay
A first subset of 300 samples were tested with the ELISA
and FMIA to evaluate the performance of both tests.
The FMIA had superior performance compared to the
ELISA. Specifically, the FMIA had an area under the
curve (AUC) of 94.8% (95% CI, 91–98%) indicating a
high accuracy of the test. The optimal cut-off was deter-
mined to be 1073.5 MFI giving a diagnostic sensitivity
and specificity of 89.7 and 92.9% respectively. The ELISA
had an AUC of 64.7% (95% CI, 55–74%) and a sensitivity
and specificity of 61 and 53% for the optimal cut-off
which had an S/P value of 22%.
ELISA and FMIA had an agreement of 79% and a
kappa value of 0.31 showing a fair agreement. FMIA was
preferred because it was more accurate, sensitive, spe-
cific, and easy to operate than the ELISA and was
selected to test the remaining field samples. The per-
centage of agreement of the FMIA and GAT was 93%
(95% CI, 88–96%) which was almost perfect (κ = 0.83).
McNemar’s test showed that the paired discordances oc-
curred randomly and therefore, both tests were compar-
able (McNemar’s p value = 1). The CVs obtained for the
FMIA test for the positive (13.1%) and negative (14%)
reference sera were considered good suggesting a high
level of assay reproducibility.
Antibody titres on field and experimental samples
Experimentally vaccinated cattle developed antibodies
against E. rhusiopathiae as demonstrated by the FMIA,
ELISA and GAT (Fig. 1, Table 1). Both cows had detect-
able antibodies on 14 dpv and antibody levels remained
detectable until the 42 dpv. MFI and GAT titres were
higher in experimentally vaccinated cattle compared to
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non-vaccinated field cattle with natural exposure. The
distribution of GAT titres against E. rhusiopathiae for
the studied bovine samples is summarized in Table 1.
The majority of positive field samples had GAT titres of
32 (22%, 36/162), followed by 64 (13%, 21/162) and 128
(13%, 5/16). The majority of the samples tested showed
agglutination below the cut-off (50%, 81/162). High anti-
body titres were detected more frequently in British cat-
tle compared to US cattle (Table 1).
MFI and GAT titres were plotted and showed a good
correlation (Fig. 2) which was supported by Pearson co-
efficient (r = 0.93).
Erysipelothrix antibody rates in US and British cattle herds
by FMIA
Antibodies against E. rhusiopathiae were present in both
populations of farmed cattle at a low level. Overall, the
prevalence in the studied British cattle population was
13.8% (51/370). Positive cattle were identified in 34.3%
(24/70) of the farms tested with an on-farm prevalence
of 7.1 to 100%. The number of seropositive cows among
the sampled US population was 6% (12/200), positive
cattle were identified in 34.7% (8/23) of the investigated
farms, and the on-farm prevalence ranged from 8.3–
30%. The difference in the prevalence between the US
and Great Britain was statistically significant by Chi-
square test (p = 0.0047, χ2 = 7.99) and the difference in
prevalence between farms was statistically significant for
British farms (p = 0.002, Fisher value = 86.5) but not for
US farms (p = 0.23, Fisher value = 18.9).
Discussion
The GAT was used as the reference test as it is the
only methodology used so far to evaluate the Erysipe-
lothix antibody responses in cattle. The FMIA devel-
oped in this study is an improved tool for the
detection of Erysipelothix antibodies in cattle and had
almost perfect agreement with the GAT, with a high
sensitivity and high specificity. There are three main
disadvantages of the GAT. First, the assay is time
Fig. 1 Erysipelothrix rhusiopathiae antibody levels in vaccinated cows. Median fluorescent intensity (MFI) (a) and ELISA optical density (OD) (b)
values before vaccination (day 0) or at day post vaccination (dpv) 14, 28 and 42 days. Vaccination was done using an Erysipelothrix rhusiopathiae
vaccine on dpv 0 and 14. Values represent the average of three repeats (+/− 2 SE)
Table 1 Distribution of growth agglutination test (GAT) Erysipelothrix rhusiopathiae antibody titres (cut-off 1:32) in cattle of unknown
Erysipelothrix spp. status (British and US herds), cows experimentally vaccinated (VAC), or in gnotobiotic calves
GAT titre 0 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 Total
British herds 8 12 12 34 30 17 5 112
US herds 12 14 3 6 6 4 50
VAC cow 1 dpv 0 dpv 14 dpv 42, 28 4
VAC cow 2 dpv 0 dpv 14 dpv 28, 42 4
Gnotiobiotc 10 10
Dpv day post vaccination with an Erysipelothrix rhusiopathiae vaccine
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consuming as only 8 samples can be included in a
plate with two overnight incubations, one to prepare
the inoculum and a second one to read the results.
Second, the GAT is hazardous since live pathogenic
bacteria have to be used. Finally, and third, the re-
sults are read by naked eye which may be subjective
and variable between operators. In contrast, the FMIA
permits the testing of large numbers of samples in
less than 4 h and gives precise and objective results.
For these reasons, we propose in here the use of
FMIA as an alternative to GAT.
The specificity of the GAT in cross-reaction with anti-
bodies against organisms other than E. rhusiopathiae
has not been studied in detail. The cross-reactivity of
rSpaA415 has been validated with pig pathogens but it
remains unknown for pathogens infecting cattle. Higher
specificity is predicted by using FMIA than GAT as the
GAT involves an extent of non-specific agglutination
since a titre of less of 32 indicates a negative reaction.
Differences in sensitivity and specificity between GAT
and FMIA could be due to the Erysipelothrix serotypes
infecting cattle. The serotype used in the GAT is sero-
type 1a but it is uncertain to what extent the GAT ag-
glutinates across different E. rhusiopathiae strains or
other Erysipelothrix species. Antibody responses against
rSpaA415 were detected in sera from rabbits inoculated
with E. rhusiopathiae serotypes containing Spa A (1a,
1b, 2, 5, 9, 12, 15, 16, 17 and 23), Spa B1 (4, 6, 8, 19 and
21), Spa B2 (11) and E. sp. strain 2 containing Spa C
(serotype 18). In contrast, low antibody responses were
observed in sera from rabbits inoculated with E.
tonsillarum serotype 20 (no Spa type) and no antibody
response was observed in sera from rabbits inoculated
with the remaining serotypes without Spa type (E. tonsil-
larum and E. sp. strain 1) [6]. The knowledge of the Ery-
sipelothrix serotypes infecting cattle is limited; one study
in Japan recovered 79 Erysipelothrix isolates from the
tonsils of healthy slaughtered cattle of which only 43 out
of these isolates were typeable and were classified into
the serotypes 1b, 2, 3, 5, 9, 12, 13, 19 and 21. Responses
against rSpaA415 were detected in rabbits infected with
serotypes 1b, 2, 5, 9, 12, 19 and 21 but not with sero-
types 3 and 13 [6]. There is no data of the serotypes of
the Erysipelothix serotypes circulating among the US
and British herds but in Norway, a serotype 5 was
isolated from an heifer with fatal metritis [13].
This study showed that FMIA was more sensitive and
specific than the ELISA using the same antigen. Higher
sensitivity of FMIA assays than ELISA have been re-
ported in other studies [21, 23, 24]. Higher sensitivity of
the FMIA in comparison to the ELISA using the
rSpaA415 protein was observed in experimentally in-
fected pigs, where the FMIA could detect more pigs with
an Erysipelothrix IgG antibody response than the ELISA
at day 7 post challenge. The overall sensitivity in experi-
mentally infected pigs was 94.4% for the FMIA and
73.6% for the ELISA [21].
The higher specificity of FMIA assays has been sug-
gested due to proteins covalently coupled to micro-
spheres, and antigen purity eliminates nonspecific
reactions that often cause high background problems in
ELISA [25]. The lower background may increase the
Fig. 2 Distribution of Erysipelothrix rhusiopathiae titers in field and experimental samples (n = 181). Vertical dashed line represents the growth
agglutination test (GAT) cut-off (1:32) and the horizontal line the fluorescent microbead-based immunoassay (FMIA) cut-off (1073.5)
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detection limit on samples with a low antibody concen-
tration [21].
Because there are no studies outside Japan that have
investigated the seroprevalence of E. rhusiopathiae in
bovine samples, we considered this knowledge gap im-
portant. Although the number of samples is limited to
extrapolate the prevalence obtained in this study with
the general prevalence in UK and US herds, this work
represents the first study investigating E. rhusiopathiae
in British and US cattle and the results suggest that E.
rhusiopathiae infections in cattle occurs at low likely
subclinical levels. All the animals sampled in this study
were healthy and had no clinical signs, suggesting that as
reported before [3, 16], asymptomatic cattle could be
carrying the bacterium.
Although the percentage of farms with seropositive
cows was nearly the same in both countries; the overall
prevalence in the sampled British herds (13.8%) was sig-
nificantly higher than in the US (6%) and positive British
cattle had higher antibody titres when compared to the
studied US herd. The reason for this is not clear; in
Japan, higher cattle antibody rates were obtained where
there were also areas of swine industry [3]. This associ-
ation could not be studied in the present work, since the
information about the location and biosecurity measures
of the sampled farms was not provided. It is worthy to
mention however, that in the most common type of
farming in the UK cows are kept on pasture during the
grass growing seasons while this may not be the case in
the US. The outdoor access and the biosecurity mea-
sures intrinsically associated with this type of farming
could be an explanation for the higher prevalence in the
British cattle as animals would have more chance to get
in contact with the bacterium than US cattle. Neverthe-
less, this conjecture needs further investigation as there
are not studies that compare the prevalence on different
farming systems and also, we do not know the location
of the farms sampled in the study and thus we have no
manner to support this hypothesis.
Challenge studies in pigs have shown that a titre above
32 in the GAT indicates protective immunity against in-
fection but it is unknown whether this applies also to
cattle. The cattle vaccinated with the pig vaccine showed
much higher antibody titres (GAT 256–1024, MFI 10,
000-19,000) than the E. rhusiopathiae positive unvaccin-
ated field cows (GAT 32–128, MFI 1074–6800).
Seroprevalence studies in other ruminant species be-
sides cattle are virtually absent; only one Japanese study
found a seroprevalence of Erysipelothix of 13.5% among
52 wild deer (Cervus nippon yesoensis and Cervus nippon
centralis), also using the GAT [26].
The obtained results suggest that 13.8 and 6% of the
farmed British and US cattle have had exposure to Erysi-
pelothrix spp. and could be carriers of the bacteria and
be a potential source of infection for other animals and
humans. Furthermore, 34.4 and 34.7% of the sampled
farms in Great Britain and the US had at least one sero-
positive animal. This data is of epidemiological import-
ance as the bacterium has been isolated from cow slurry
[3] and it is very resistant to environmental challenges
[4], being able to survive in contaminated soil for several
months [8]. Preventive measures should be implemented
to avoid the transmission of the pathogen, especially
among, abattoir workers, butchers, farmers and veteri-
narians that are at higher risk of exposure [27].
Conclusions
This work is the first one investigating the seropreva-
lence of E. rhusiopathiae among North American and
British cattle and results showed that, although at low
frequency, cattle are exposed to the bacterium and
therefore could act as a reservoir of transmission of the
disease. The newly developed FMIA test represents an
improvement on the serodiagnosis of this bacterium in
cattle as it is fast, proving objective results, sensitive
(89.7%), specific (92.9%) and has a good agreement with
the reference assay GAT.
Methods
Serum samples
Cattle with known Erysipelothrix exposure
Two adult Angus feedlot cattle, part of the Iowa State
University teaching herd and located in Ames, IA, USA
were vaccinated with a commercial vaccine licensed for
pigs (MaGESTic® 7 with SPUR®; Intervet Inc., DE, USA,
serial number: 0784A009A) twice with 14 days interval
by injecting 2 ml of the vaccine intramuscular into the
neck area. Blood samples were collected before vaccin-
ation (day 0) and at days 14, 28 and 42 post vaccination
(dpv), centrifuged, and the serum was collected and used
for further analysis. The two cattle remained in the
teaching herd after the experiment ended. In addition,
10 archived serum samples from gnotobiotic calves from
an unrelated study (kindly provided by Dr. Geraldine
Taylor, Pirbright Institute, Surrey, UK) were used as
controls.
Field samples
A total of 200 US feedlot cattle serum samples submitted
for routine diagnostics were obtained from the Veterinary
Diagnostic Laboratory at Iowa State University, Ames, IA,
USA (kindly provided by Dr. David Baum) and 370 serum
samples were obtained from Scottish dairy cattle through
the Scottish Agricultural College (SAC), Midlothian, UK
(kindly provided by Dr. Jill Thomson). All animals were at
least 1 year old (adults), healthy and had no clinical signs.
The serum samples corresponded to 23 US farms with an
average of 8.6 animals per farm (min = 1, max = 15,
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median = 10) and 70 Scottish farms with an average of 5.3
animals per farm (min = 1, max = 15, median = 3).
Serological assays
ELISA and FMIA development
The recombinant protein rSpaA415, based on the major
surface protective antigen A (SpaA) [6, 21] was used as
antigen in both ELISA and FMIA. The optimal dilution
of the serum sample and regents was determined by a
checkerboard titration in both assays.
For the FMIA, 18 μg of the polypeptide rSpaA415 was
coupled to 5 million of microbeads (bead region 45,
Luminex Corp., TX, USA) using a 2 step carbodiimide
reaction [21]. All the incubations were carried out for
30 min at room temperature, in the dark and under con-
tinuous shaking. Washing steps were performed using a
magnetic separator and 200 μl of washing buffer com-
posed of PBS with 0.05% of Tween 20, pH 7.4 (PBST).
Coupled beads were diluted in blocking buffer (Stabi-
lGuard; Surmodics, MN, USA) to a final concentration of
2500 beads per well and 50 μl of this solution were incu-
bated with 50 μl of each serum sample diluted 1:800 in assay
buffer (PBST containing 10% goat serum). The plate then
was incubated and washed three times with washing buffer.
Following this, 50 μl of a 20,000 dilution of a biotin conju-
gated goat anti-bovine IgG (Jackson Immuno Research,
Cambridge, UK) was added to the wells and incubated for
another 30min. After three washings, 50 μl of streptavidin
R-phycoerythrin conjugate (SAPE; MOSS, MD, USA) at 1:
100 dilution in assay buffer were added to the wells. Finally,
after the last incubation and washing steps, beads were re-
suspended in 100 μl of assay buffer and analysed using a
MAGPIX® reader system (Luminex corp., TX, USA).
The in-house ELISA was performed in 96 well plates
(MaxiSorp™; Nunc, NY, USA) coated with 0.3 μg/ml of
rSpaA415 polypeptide and blocked using PBS with 10%
chicken serum (Biowest, MO, USA) for 2 h at room
temperature. The samples were diluted at 1:800 with PBS
containing 10% rabbit serum (Biowest, MO, USA) and
100 μl was added to each well of the plate and left to incu-
bate for 30min at 37 °C. After washing the plates, 100 μl of a
1:30,000 dilution of peroxidase-conjugated rabbit anti-bovine
(Jackson Immuno Research, Cambridge, UK) was added to
each well and left to incubate for 30min at 37 °C. After the
final washing, 100 μl of tetramethylbenzidine-hydrogen per-
oxide (TMB) was added to each well as a substrate (KPL,
MD, USA) and left for 15min for colour to develop. The
peroxidase reaction was stopped by adding 50μl of 1% HCl
solution (KPL, MD, USA) into each well. The optical density
was then read at 450 nm using a spectrophotometer.
Growth agglutination test
The growth agglutination test was conducted to deter-
mine the agglutinating antibody titres of the sera as
described elsewhere [3, 17, 18]. Briefly, 50 μl of each
serum sample was incubated for 1 h at 37 °C with 50 μl
of 0.2 M 2-Mercaptoethanol (Sigma Aldrich, MO, USA).
Two-fold dilutions (1:2 to 1: 2048) of the serum were
made in brain heart infusion broth supplemented with
0.1% Tween 80 (BHI-T80), 0.3% Tris-HCl (pH 8.0),
kanamycin (100 μg/ml) and gentamicin (50 μg/ml) in a
96 well plate. Following this, 50 μl of the E. rhusio-
pathiae strain E1-6P (serotype 1a), diluted 1:10 after an
18 h incubation in BHI-T80, was added to each of the
wells. Agglutination reactions were read after incubation
at 37 °C for 18 h. The titres were expressed as the recip-
rocal of the number of the highest dilution of serum that
showed agglutination.
Data analysis
Statistical evaluations were performed with the package
SPSS (v.19). Statistical significance was set at a p value
of < 0.05. The level of agreement between tests was
determined using Cohen’s Kappa and the percentage of
agreement. Pearson coefficient was used to measure the
level of correlation between tests. Kappa coefficients (k)
with values between 0 and 0.01, 0.02–0.2, 0.21–0.4,
0.41–0.6, 0.61–0.8 and 0.81–1 were interpreted as no
agreement, slight, fair, moderate, substantial and almost
perfect agreement respectively [28]. Marginal homogen-
eity of paired data was tested by McNemar’s Chi-square
test [29]. Assay results were expressed as Median Fluor-
escent Intensity (MFI) for FMIA and Optical Density
(OD) and S/P value calculated as the (average OD sam-
ple/OD positive reference control) × 100 for the ELISA.
The inter-assay variance was calculated using the coeffi-
cient of variance (CV) for a positive and a negative. CV
with values < 10, 10–15%, 15–20%, > 20% were consid-
ered excellent, good, acceptable and excessive. A set of
field samples (n = 163) were chosen based on MFI and
OD values and all available controls (n = 18) and GAT
was used as reference test to classify samples as positive
or negative and MFI and S/P value were analysed in a
ROC curve to generate an optimised cut-off [30].
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